Literature DB >> 30991392

Definition and Validity of the Construct "Problematic Khat Use": A Systematic Review.

Awoke Mihretu1,2, Clement Nhunzvi3, Abebaw Fekadu4,5,6,7, Sam Norton8, Solomon Teferra4,9.   

Abstract

BACKGROUND: Problematic khat use, not khat use per se, is a public health and social concern for the public, researchers, and policy makers. However, the construct problematic khat use is not well-established and not fully recognized in the modern definition of substance use disorders including Diagnostic Statistic Manual (DSM-5) and international classification of diseases (ICD-10), although DSM-5 included it in the "stimulant use disorder" category. Existing scoping reviews have focused on khat use, which could not allow the differentiation of khat use from problematic khat use. Thus, the aim of this systematic review was to define and validate the construct problematic khat use.
METHODS: This systematic review was reported following the PRISMA guidelines. We searched all English language studies without publication date restriction from 5 databases; PubMed, EMBASE, psychINFO, SocINDEX, and Google scholar. All studies that defined, explored, evaluated, or measured the construct problematic khat use were included. Adapted data extraction tool and criteria for quality evaluation were employed. We presented the results in tables and thematic synthesis of the major findings. RESULT: Overall, 30 qualitative and cross-sectional design studies were included. Associated harms with khat use, an increased amount used, increased frequency of use, and withdrawal experiences were indicators of problematic khat use. Using khat on an average of 3 or more times per week and using other psychoactive substances during and after khat use were frequently used to define problematic khat use. The most frequently reported withdrawal symptoms were depressed mood, irritability, fatigue, lack of motivation, increased sleep, and appetite. The existing measures (severity of dependence scale and DSM-5) of problematic khat use had psychometrically acceptable properties in terms of construct, criterion, and convergent validity, but they are poor in terms of other domains of validity including content, conceptual, and semantic validity.
CONCLUSION: Problematic khat use constitutes, but is not limited to, harms, increased use over time, and frequent engagement in other psychoactive substances misuse. Khat use is different from problematic khat use since it is occasional and used for prayer, social, and functional reasons. Strong empirical studies that could establish thresholds for patterns of problematic khat use and a culturally suitable problematic khat use measures that follows a bottom-up approach of scale development are warranted.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Khat use; Khat use disorder; Problematic khat use; Substance misuse; Systematic review

Mesh:

Substances:

Year:  2019        PMID: 30991392     DOI: 10.1159/000499970

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  3 in total

1.  Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges.

Authors:  Benoit Schreck; Marylène Guerlais; Edouard Laforgue; Célia Bichon; Marie Grall-Bronnec; Caroline Victorri-Vigneau
Journal:  Front Psychiatry       Date:  2020-07-22       Impact factor: 4.157

2.  Developing sustainable capacity-building in mental health research: implementation outcomes of training of trainers in systematic reviewing.

Authors:  Helen E Jack; Christopher Merritt; Girmay Medhin; Rosemary Musesengwa; Chitsanzo Mafuta; Lorna J Gibson; Charlotte Hanlon; Katherine Sorsdahl; Dixon Chibanda; Melanie Abas
Journal:  Glob Health Action       Date:  2020       Impact factor: 2.640

3.  Exploring the concept of problematic khat use in the Gurage community, South Central Ethiopia: a qualitative study.

Authors:  Awoke Mihretu; Abebaw Fekadu; Kassahun Habtamu; Clement Nhunzvi; Sam Norton; Solomon Teferra
Journal:  BMJ Open       Date:  2020-10-12       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.